MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
11.22
+2.35
+26.49%
After Hours: 11.15 -0.07 -0.62% 16:02 11/11 EST
OPEN
9.85
PREV CLOSE
8.87
HIGH
11.23
LOW
9.01
VOLUME
9.90M
TURNOVER
--
52 WEEK HIGH
40.37
52 WEEK LOW
2.960
MARKET CAP
652.32M
P/E (TTM)
-4.5809
1D
5D
1M
3M
1Y
5Y
1D
Capricor Therapeutics Price Target Announced at $25.00/Share by Jones Trading
Dow Jones · 28m ago
Capricor Therapeutics Raised to Buy From Hold by Jones Trading
Dow Jones · 28m ago
Jones Trading Upgrades Capricor Therapeutics to Buy, Announces $25 Price Target
Benzinga · 37m ago
Notable Wednesday Option Activity: AAP, CAPR, FSLR
NASDAQ · 1h ago
Biotech And Healthcare Stocks Move Higher: KRMD, CARL Surge 24%, AZTA Climbs 23%
NASDAQ · 2h ago
Capricor jumps as Jones upgrades ahead of FDA decision on lead asset
Seeking Alpha · 2h ago
Opco sees Capricor shares moving to $50 on FDA approval
TipRanks · 3h ago
Capricor Therapeutics upgraded to Buy from Hold at Jones
TipRanks · 4h ago
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program focuses on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, Deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. The clinical development program for Deramiocel has focused primarily on adolescents and young adults with DMD, including many patients who are non-ambulatory and experiencing progressive cardiac and skeletal muscle decline. Its StealthX exosome platform program consists of engineered exosomes for vaccine and therapeutic development. The StealthX vaccine is a proprietary vaccine developed internally utilizing exosomes that were engineered to express either spike or nucleocapsid proteins on the surface.

Webull offers Capricor Therapeutics Inc stock information, including NASDAQ: CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.